These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 35538118)

  • 1. Strategic spatiotemporal vaccine distribution increases the survival rate in an infectious disease like Covid-19.
    Grauer J; Löwen H; Liebchen B
    Sci Rep; 2020 Dec; 10(1):21594. PubMed ID: 33299029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemic Vulnerability Index for Effective Vaccine Distribution Against Pandemic.
    Lee H; Kang M; Kim D; Seo D; Li Y
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(6):3332-3342. PubMed ID: 35984789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    Matter D; Potgieter L
    PLoS One; 2021; 16(3):e0248053. PubMed ID: 33667263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine rollout strategies: The case for vaccinating essential workers early.
    Mulberry N; Tupper P; Kirwin E; McCabe C; Colijn C
    PLOS Glob Public Health; 2021; 1(10):e0000020. PubMed ID: 36962089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.
    Espinosa O; Mora L; Sanabria C; Ramos A; Rincón D; Bejarano V; Rodríguez J; Barrera N; Álvarez-Moreno C; Cortés J; Saavedra C; Robayo A; Franco OH
    Syst Rev; 2024 Jan; 13(1):30. PubMed ID: 38229123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccination patterns and vaccination rates on the spread and mortality of the COVID-19 pandemic.
    Chen YT
    Health Policy Technol; 2023 Mar; 12(1):100699. PubMed ID: 36415885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose.
    Berec L; Levínský R; Weiner J; Šmíd M; Neruda R; Vidnerová P; Suchopárová G
    Sci Rep; 2022 May; 12(1):7638. PubMed ID: 35538118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.
    Souto Ferreira L; Canton O; da Silva RLP; Poloni S; Sudbrack V; Borges ME; Franco C; Marquitti FMD; de Moraes JC; Veras MASM; Kraenkel RA; Coutinho RM
    PLoS Comput Biol; 2022 Mar; 18(3):e1009978. PubMed ID: 35333872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling waning and boosting of COVID-19 in Canada with vaccination.
    Childs L; Dick DW; Feng Z; Heffernan JM; Li J; Röst G
    Epidemics; 2022 Jun; 39():100583. PubMed ID: 35665614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
    BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Silva PJS; Sagastizábal C; Nonato LG; Struchiner CJ; Pereira T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34408076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
    Andrews N; Stowe J; Kirsebom F; Toffa S; Rickeard T; Gallagher E; Gower C; Kall M; Groves N; O'Connell AM; Simons D; Blomquist PB; Zaidi A; Nash S; Iwani Binti Abdul Aziz N; Thelwall S; Dabrera G; Myers R; Amirthalingam G; Gharbia S; Barrett JC; Elson R; Ladhani SN; Ferguson N; Zambon M; Campbell CNJ; Brown K; Hopkins S; Chand M; Ramsay M; Lopez Bernal J
    N Engl J Med; 2022 Apr; 386(16):1532-1546. PubMed ID: 35249272
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.